|
Carcinoma, Transitional Cell
|
0.010 |
Biomarker
|
disease |
BEFREE |
The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.
|
30416134 |
2020 |
|
Hydronephrosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
As the degree of hydronephrosis increased, the expression of neutrophil percentage, CysC, blood urea nitrogen, SCr and serum uric acid also increased.
|
31801142 |
2020 |
|
Urothelial Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.
|
30416134 |
2020 |
|
RETINOSCHISIS 1, X-LINKED, JUVENILE
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RA+RS signifificantly decreased the diastolic blood pressure, renal vascular resistance index, and parenchymal thickness, increased 24 h urinary volume as well as lowered the levels of urine mALB and serum cystatin ^C, IL-1β and β2-Mg of SHRs (P <0.05 vs. SHRs).
|
31388973 |
2020 |
|
Acute-On-Chronic Liver Failure
|
0.010 |
Biomarker
|
disease |
BEFREE |
This study aimed to compare the performance of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C (CysC) in predicting the 90-day mortality in patients with hepatitis B virus (HBV)-associated ACLF (HBV-ACLF).
|
31113585 |
2020 |
|
Lumbodynia
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
We found that urodynia or lumbodynia was more prevalent in women with CST4 than in women with CST3, and cervical hypertrophy was more prevalent in women with CST4 than in women with CST2 and CST3.
|
31841701 |
2020 |
|
Aortic Aneurysm
|
0.010 |
Biomarker
|
disease |
BEFREE |
More cathepsin L-positive cells were observed in the AA group than in the DM+AA group; conversely, more cystatin C-positive cells were observed in the DM+AA group than in the AA group.
|
31096818 |
2019 |
|
Asthma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A higher likelihood of asthma remission was associated with a greater decrease in leptin levels, and a higher likelihood of diabetes remission was predicted by a lesser decrease in CC.
|
29777230 |
2019 |
|
Cognition Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
Cystatin isolated from chicken egg white, called ovocystatin, has been widely used in the medical and pharmaceutical research due to its structural and biological similarities to human cystatin C. The aim of this study was to assess the effect of administering ovocystatin on the development of dementia-specific cognitive deficits in APP/PS1 transgenic mice.
|
30504006 |
2019 |
|
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The present study aimed to describe a new sarcopenia index (SI), serum creatinine (Scr) × cystatin C-based glomerular filtration rate, and investigate its association with short-term complications after curative resection of CRC.
|
30648340 |
2019 |
|
Dysautonomia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Therefore, the aim of this study was to investigate the relationship between CysC and cardiovascular autonomic dysfunction in type 2 diabetic patients without renal dysfunction.
|
31011584 |
2019 |
|
Dyskinetic syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Measurement of serum cystatin C: A valuable tool for evaluating dyskinesia in Parkinson's disease.
|
31054924 |
2019 |
|
Angle Closure Glaucoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We assume that elevated levels of OPN and cystatin C in POAG and PACG along with altered cathepsin levels may contribute to ECM aberration in glaucoma.
|
30994369 |
2019 |
|
Primary angle-closure glaucoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We assume that elevated levels of OPN and cystatin C in POAG and PACG along with altered cathepsin levels may contribute to ECM aberration in glaucoma.
|
30994369 |
2019 |
|
Immune System Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Our results might open up an avenue for the development of therapeutic agents for the treatment of cystatin C-related immunological diseases.
|
31513306 |
2019 |
|
Nephrocalcinosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Children born EPT had significantly smaller kidneys (EPT (NC+ NC-) vs control (estimated difference, 11.8 (CI - 21.51 to - 2.09 ml), p = 0.018) and lower but normal cystatin C-based glomerular filtration rate compared with control (estimated difference, - 10.11 (CI - 0.69 to - 19.5), p = 0.035).
|
31338588 |
2019 |
|
Nephrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
This longitudinal, prospective study analyzed the first-year profile of two serum renal biomarkers: creatinine (sCr) and cystatin C (sCyC); and six urinary renal biomarkers: neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), transforming growth factor beta-1 (TGF-β1), retinol-binding protein (RBP), cystatin C (uCyC), and microalbuminuria (μALB) in a cohort of 37 infants with UTO divided into three subgroups: 14/37 with unilateral hydro(uretero)nephrosis, 13/37 with bilateral hydro(uretero)nephrosis, and 10/37 patients with lower urinary tract obstruction (LUTO), compared with 24 healthy infants matched by gestational age and birth weight.
|
30694385 |
2019 |
|
Nephrotic Syndrome
|
0.010 |
Biomarker
|
group |
BEFREE |
This longitudinal, prospective study analyzed the first-year profile of two serum renal biomarkers: creatinine (sCr) and cystatin C (sCyC); and six urinary renal biomarkers: neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), transforming growth factor beta-1 (TGF-β1), retinol-binding protein (RBP), cystatin C (uCyC), and microalbuminuria (μALB) in a cohort of 37 infants with UTO divided into three subgroups: 14/37 with unilateral hydro(uretero)nephrosis, 13/37 with bilateral hydro(uretero)nephrosis, and 10/37 patients with lower urinary tract obstruction (LUTO), compared with 24 healthy infants matched by gestational age and birth weight.
|
30694385 |
2019 |
|
Peripheral Neuropathy
|
0.010 |
Biomarker
|
group |
BEFREE |
Previous studies have proved that cystatin C (CysC) is an important predictor of both peripheral neuropathy and cardiovascular events.
|
31011584 |
2019 |
|
Sleep Apnea Syndromes
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Baseline CRP levels were positively associated with the odds of asthma but not diabetes or sleep apnea; baseline CC levels were positively associated with asthma, diabetes, and sleep apnea; baseline leptin levels were positively associated with asthma and negatively associated with diabetes and sleep apnea; baseline ghrelin levels were negatively associated with diabetes and sleep apnea.
|
29777230 |
2019 |
|
Thalassemia
|
0.010 |
Biomarker
|
group |
BEFREE |
We identified 91 participants with HbSS or SB0 thalassemia 5-21 years of age enrolled in a longitudinal sickle cell nephropathy cohort study who had a cystatin C measured during early childhood (4-10 years of age).
|
30592084 |
2019 |
|
Peripheral Vascular Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Clinical significance First prospective longitudinal cohort study evaluating Cystatin C, copeptin, N-terminal pro-B-type natriuretic peptide (N-BNP), midregional proatrial natriuretic peptide (MR-proANP), and mid-regional proadrenomedullin (MR-proADM) as predictors for peripheral arterial disease (PAD).
|
31215249 |
2019 |
|
Complete atrioventricular block
|
0.010 |
Biomarker
|
disease |
BEFREE |
INR, creatinine, NAG, and CysC are proper biomarkers for screening renal dysfunction in Chinese patients with CHB or compensated LC.
|
30830657 |
2019 |
|
Congenital heart disease
|
0.010 |
Biomarker
|
group |
BEFREE |
Creatinine versus cystatin C to estimate glomerular filtration rate in adults with congenital heart disease: Results of the Boston Adult Congenital Heart Disease Biobank.
|
31203159 |
2019 |
|
Sickle cell nephropathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
We identified 91 participants with HbSS or SB0 thalassemia 5-21 years of age enrolled in a longitudinal sickle cell nephropathy cohort study who had a cystatin C measured during early childhood (4-10 years of age).
|
30592084 |
2019 |